Citalopram augmentation of antipsychotic treatment in older schizophrenia patients

International Journal of Geriatric Psychiatry

Volumn 16, Issue 12, 2001, Pages 1163-1167

  Kasckow, John W ^a,b,e   Mohamed, Somaia ^a,b   Thallasinos, Arthur ^a,b   Carroll, Brendan ^a,b   Zisook, Sidney ^c,d   Jeste, Dilip V ^c,d  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Cincinnati VA Medical Cente   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d San Diego VA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antidepressants; Older adults; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; FOLLOW UP; GERIATRIC PATIENT; HAMILTON SCALE; HOSPITALIZATION; HUMAN; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SIDE EFFECT; SINGLE BLIND PROCEDURE; SYMPTOM;

AGED; ANTIPSYCHOTIC AGENTS; CITALOPRAM; DEPRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PERSONALITY INVENTORY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0035678743     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.508     Document Type: Article

References (20)

1. Studies of the course and outcome of schizophrenia in later life
2. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
3. A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia
4. Clinical global impressions
5. Development of a rating scale for primary depressive illness
6. Serotonin syndrome during treatment with paroxetine and risperidone
7. Suicide and schizophrenia: A nationwide psychological autopsy study on age-and sex-specific clinical characteristics of 92 suicide victims with schizophrenia
8. Association of depressive symptoms and functioning in schizophrenia. A study in older outpatients
9. The significance of depression in the prediction of relapse in chronic schizophrenia
10. The positive and negative syndrome scale (PANSS) for schizophrenia
11. Treatment of secondary depression in schizophrenia
12. Depression in the course of chronic undifferentiated schizophrenia
13. Citalopram as an adjuvant in chronic schizophrenia: A double blind placebo controlled study
14. Treatment options for refractory depression
15. Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled study
16. Depression in schizophrenia: Perspective in the era of 'atypical' antipsychotic agents
17. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia
18. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: An open-label case series
19. Depressive symptoms in schizophrenia